Symbols / TTRX Stock $3.80 +2.97% Turn Therapeutics Inc.
TTRX (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
Ratings
Current target
$3.80
Low
$8.00
High
$8.00
Mean
$8.00
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-03-24 | main | D. Boral Capital | Buy → Buy | $8 |
| 2026-01-20 | main | D. Boral Capital | Buy → Buy | $8 |
| 2025-12-29 | init | D. Boral Capital | — → Buy | $8 |
- symbol__ Stock Quote Price and Forecast - CNN Wed, 08 Oct 2025 14
- TTRX Price Today: Turn Therapeutics Inc. Stock Price, Quote & Chart | MEXC - MEXC Sun, 26 Apr 2026 16
- Bradley Burnam holds 52.76% of Turn Therapeutics (NASDAQ: TTRX) common stock - Stock Titan Mon, 06 Apr 2026 07
- Turn Therapeutics (NASDAQ:TTRX) Trading 6% Higher - Should You Buy? - MarketBeat Sat, 25 Apr 2026 06
- TTRX Stock Price and Chart — NASDAQ:TTRX - TradingView Sun, 12 Oct 2025 07
- Great week for Turn Therapeutics Inc. (NASDAQ:TTRX) insiders who have 59% stake and they haven’t stopped buying - Yahoo Finance hu, 08 Jan 2026 08
- Turn Therapeutics Inc. Begins Trading on NASDAQ and Strengthens Leadership with Key Appointments and Strategic Partnership | TTRX Stock News - Quiver Quantitative hu, 13 Nov 2025 08
- TTRX Stock Price, Quote & Chart | TURN THERAPEUTICS INC (NASDAQ:TTRX) - ChartMill Wed, 08 Oct 2025 07
- 80K options granted at $3.12 to Turn Therapeutics (TTRX) - Stock Titan Fri, 03 Apr 2026 07
- Insider Stock Purchases: October 24, 2025 - Quiver Quantitative Fri, 24 Oct 2025 07
- Turn Therapeutics (TTRX) Stock Forecast and Price Target 2026 $TTRX - MarketBeat hu, 30 Oct 2025 20
- TTRX Stock Price, News & Analysis - Stock Titan Wed, 08 Oct 2025 15
- Turn Therapeutics (TTRX) Stock Price, News & Analysis $TTRX - MarketBeat hu, 30 Oct 2025 09
- Turn Therapeutics (TTRX) CEO-linked entity gifts 300,000 shares, retains 15.7M - Stock Titan Fri, 03 Apr 2026 07
- Turn Therapeutics (TTRX) CEO receives 160,000 stock options at $3.43 strike - Stock Titan Fri, 03 Apr 2026 07
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
| Operating Expense |
|
1.80
-22.14%
|
2.31
|
| Research And Development |
|
0.25
+3179.41%
|
0.01
|
| Selling General And Administration |
|
1.55
-32.58%
|
2.30
|
| General And Administrative Expense |
|
1.55
-32.58%
|
2.30
|
| Other Gand A |
|
1.55
-32.58%
|
2.30
|
| Total Expenses |
|
1.80
-22.14%
|
2.31
|
| Operating Income |
|
-1.80
+22.14%
|
-2.31
|
| Total Operating Income As Reported |
|
-1.80
+22.14%
|
-2.31
|
| EBITDA |
|
-1.75
+22.73%
|
-2.26
|
| Normalized EBITDA |
|
-1.75
+22.73%
|
-2.26
|
| Reconciled Depreciation |
|
0.05
+8.11%
|
0.04
|
| EBIT |
|
-1.80
+22.14%
|
-2.31
|
| Net Income |
|
-1.77
+22.85%
|
-2.29
|
| Pretax Income |
|
-1.77
+22.85%
|
-2.29
|
| Net Non Operating Interest Income Expense |
|
0.03
+80.76%
|
0.02
|
| Net Interest Income |
|
0.03
+80.76%
|
0.02
|
| Interest Income Non Operating |
|
0.03
+80.76%
|
0.02
|
| Interest Income |
|
0.03
+80.76%
|
0.02
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-1.77
+22.85%
|
-2.29
|
| Net Income From Continuing Operation Net Minority Interest |
|
-1.77
+22.85%
|
-2.29
|
| Net Income From Continuing And Discontinued Operation |
|
-1.77
+22.85%
|
-2.29
|
| Net Income Continuous Operations |
|
-1.77
+22.85%
|
-2.29
|
| Normalized Income |
|
-1.77
+22.85%
|
-2.29
|
| Net Income Common Stockholders |
|
-1.77
+22.85%
|
-2.29
|
| Diluted EPS |
|
-0.06
+22.85%
|
-0.08
|
| Basic EPS |
|
-0.06
+22.85%
|
-0.08
|
| Basic Average Shares |
|
29.45
+0.00%
|
29.45
|
| Diluted Average Shares |
|
29.45
+0.00%
|
29.45
|
| Diluted NI Availto Com Stockholders |
|
-1.77
+22.85%
|
-2.29
|
| Line Item | Trend | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total Assets |
|
2.05
+1.75%
|
2.01
|
| Current Assets |
|
1.10
-8.64%
|
1.20
|
| Cash Cash Equivalents And Short Term Investments |
|
0.87
-26.11%
|
1.18
|
| Cash And Cash Equivalents |
|
0.87
-26.11%
|
1.18
|
| Other Current Assets |
|
0.23
+982.25%
|
0.02
|
| Total Non Current Assets |
|
0.95
+17.15%
|
0.81
|
| Net PPE |
|
0.12
+262.57%
|
0.03
|
| Gross PPE |
|
0.12
+262.57%
|
0.03
|
| Other Properties |
|
0.12
+262.57%
|
0.03
|
| Goodwill And Other Intangible Assets |
|
0.82
+6.75%
|
0.77
|
| Other Intangible Assets |
|
0.82
+6.75%
|
0.77
|
| Non Current Prepaid Assets |
|
0.01
+0.00%
|
0.01
|
| Total Liabilities Net Minority Interest |
|
2.23
+15.49%
|
1.93
|
| Current Liabilities |
|
0.71
+44.54%
|
0.49
|
| Payables And Accrued Expenses |
|
0.67
+43.62%
|
0.46
|
| Current Debt And Capital Lease Obligation |
|
0.04
+61.63%
|
0.03
|
| Current Capital Lease Obligation |
|
0.04
+61.63%
|
0.03
|
| Total Non Current Liabilities Net Minority Interest |
|
1.52
+5.59%
|
1.44
|
| Long Term Debt And Capital Lease Obligation |
|
0.08
|
0.00
|
| Long Term Capital Lease Obligation |
|
0.08
|
0.00
|
| Non Current Deferred Liabilities |
|
1.44
+0.00%
|
1.44
|
| Non Current Deferred Revenue |
|
1.44
+0.00%
|
1.44
|
| Stockholders Equity |
|
-0.18
-306.87%
|
0.09
|
| Common Stock Equity |
|
-0.18
-306.87%
|
0.09
|
| Capital Stock |
|
0.00
+1.36%
|
0.00
|
| Common Stock |
|
0.00
+1.36%
|
0.00
|
| Additional Paid In Capital |
|
19.02
+8.60%
|
17.51
|
| Retained Earnings |
|
-19.20
-10.15%
|
-17.43
|
| Total Equity Gross Minority Interest |
|
-0.18
-306.87%
|
0.09
|
| Total Capitalization |
|
-0.18
-306.87%
|
0.09
|
| Working Capital |
|
0.39
-45.23%
|
0.71
|
| Invested Capital |
|
-0.18
-306.87%
|
0.09
|
| Total Debt |
|
0.12
+381.14%
|
0.03
|
| Capital Lease Obligations |
|
0.12
+381.14%
|
0.03
|
| Net Tangible Assets |
|
-1.00
-46.07%
|
-0.68
|
| Tangible Book Value |
|
-1.00
-46.07%
|
-0.68
|
| Line Item | Trend | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Cash Flow |
|
-1.36
+1.19%
|
-1.38
|
| Cash Flow From Continuing Operating Activities |
|
-1.36
+1.19%
|
-1.38
|
| Net Income From Continuing Operations |
|
-1.77
+22.85%
|
-2.29
|
| Depreciation Amortization Depletion |
|
0.05
+8.11%
|
0.04
|
| Depreciation And Amortization |
|
0.05
+8.11%
|
0.04
|
| Other Non Cash Items |
|
0.01
+1206.65%
|
0.00
|
| Stock Based Compensation |
|
0.35
-44.89%
|
0.64
|
| Change In Working Capital |
|
-0.00
-100.81%
|
0.23
|
| Change In Prepaid Assets |
|
-0.20
-12471.75%
|
0.00
|
| Change In Payables And Accrued Expense |
|
0.20
-2.88%
|
0.21
|
| Change In Other Working Capital |
|
—
|
0.02
|
| Investing Cash Flow |
|
-0.10
-124.52%
|
-0.04
|
| Cash Flow From Continuing Investing Activities |
|
-0.10
-124.52%
|
-0.04
|
| Capital Expenditure |
|
-0.10
-124.52%
|
-0.04
|
| Net Intangibles Purchase And Sale |
|
-0.10
-124.52%
|
-0.04
|
| Purchase Of Intangibles |
|
-0.10
-124.52%
|
-0.04
|
| Financing Cash Flow |
|
1.15
+130.48%
|
0.50
|
| Cash Flow From Continuing Financing Activities |
|
1.15
+130.48%
|
0.50
|
| Net Common Stock Issuance |
|
1.15
+130.48%
|
0.50
|
| Changes In Cash |
|
-0.31
+66.55%
|
-0.92
|
| Beginning Cash Position |
|
1.18
-43.84%
|
2.10
|
| End Cash Position |
|
0.87
-26.11%
|
1.18
|
| Free Cash Flow |
|
-1.46
-2.73%
|
-1.42
|
| Common Stock Issuance |
|
1.15
+130.48%
|
0.50
|
| Issuance Of Capital Stock |
|
1.15
+130.48%
|
0.50
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-03 View
- 42026-04-03 View
- 42026-04-03 View
- 42026-04-03 View
- 10-K2026-03-31 View
- 8-K2026-03-31 View
- 8-K2026-03-24 View
- 8-K2026-02-17 View
- 8-K2026-02-09 View
- 42026-02-04 View
- 8-K2026-01-12 View
- 8-K2026-01-07 View
- 42025-12-12 View
- 42025-11-25 View
- 42025-11-24 View
- 42025-11-21 View
- 42025-11-17 View
- 10-Q2025-11-13 View
- 8-K2025-11-13 View
- 8-K2025-11-12 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|